Adults who are daytime workers.
Conditions
Interventions
Wearable device (Fitbit Inspire 3) and smartphone app./API usage groups 1.Manage one'
s sleep time by using the wearable device with the Fitbit app. 2.Manage one'
s sleep habits using an original smartphone app. that has a function to provide feedback on habits in accordance with the sleep check sheet once a week. The above management will be conducted for ap
s sleep time by using the wearable device with the Fitbit app. The above management will be conducted for approximately 6 months
Neither wearable device nor smartphone app usage group (control gro
Sponsors
National Center of Neurology and Psychiatry
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Workers belonging to local governments, companies, or other organizations that have agreed to participate in the study and who have given their consent to this study.
Exclusion criteria
Exclusion criteria: 1. Individuals who do not own a smartphone 2. Individuals engaged in shift work 3. Individuals who often take overseas business trips with time differences 4. Individuals who are already routinely using wearable devices, including Fitbit, for sleep management and cannot follow instructions to change or stop using their wearable device 5. Others whom the principal investigator or research director deems inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Work Limitations Questionnaire Short-Form Japanese version (WLQ-SF-J) score, 8-Item Short-Form Health Survey-Japanese (SF-8-J) score | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep habits (by evaluated with Sleep Check Sheet and smartphone app and API), sleep data measured by the wearable device, bedroom environments (temperature, humidity, illuminance, atmospheric pressure, noise, vibration, eTVOC), general health examination data (height, weight, BMI, waist circumference, visual acuity, blood pressure, smoking, drinking habits, alcohol consumption, chest X-ray findings, urinary protein, urinary glucose, urobilinogen, fecal occult blood, red blood cell count, hemoglobin, hematocrit, platelet count, MCH, MCV, MCHC, white blood cell count, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, AST, ALT, gamma-glutamyltransferase, ALP, LDH, TP, Alb, BUN, creatinine, eGFR, uric acid, fasting blood glucose, HbA1c, etc.), self-efficacy scale score | — |
Countries
Japan
Contacts
Public ContactTomohiro Utsumi
National Center of Neurology and Psychiatry Department of Sleep-Wake Disorders, National Institute of Mental Health
Outcome results
None listed